Human disease-associated calmodulin mutations alter calcineurin function through multiple mechanisms

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• Calmodulin (CaM) is a crucial calcium-binding protein regulating numerous cellular processes.
• Mutations in CaM cause calmodulinopathy, a life-threatening heart condition, linked to altered interactions with ion channels and kinases.
• The impact of CaM mutations on other CaM-regulated proteins remains largely unexplored.

Purpose of the Study:

• To investigate how disease-associated CaM mutations affect the function of calcineurin (CaN), a Ca2+-activated serine/threonine phosphatase.
• To elucidate the biophysical and mechanistic basis of CaM mutation-induced CaN dysfunction.
• To explore the potential contribution of altered CaN function to the pathogenesis of calmodulinopathy.

Main Methods:

• Circular dichroism (CD) spectroscopy
• Solution Nuclear Magnetic Resonance (NMR) spectroscopy
• Stopped-flow kinetic measurements
• Molecular Dynamics (MD) simulations
• Biophysical characterization of CaN-CaM interactions

Main Results:

• Specific CaM point mutations (N53I, F89L, D129G, F141L) were found to impair CaN phosphatase activity.
• Mutations differentially affected CaM binding affinity, calcium (Ca2+) binding, and Ca2+ dissociation kinetics.
• Structural analysis revealed alterations in the CaN-CaM complex, suggesting impaired allosteric signaling.
• The degree of CaN inhibition varied among the tested CaM mutants.

Conclusions:

• Disease-associated CaM mutations disrupt CaN function through diverse mechanisms.
• Altered CaN activity due to CaM mutations represents a potential novel mechanism contributing to calmodulinopathy.
• These findings expand our understanding of CaM's role in cardiovascular health and disease, highlighting CaN as a key player.